Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2024-09-17 00:00:00 ET · period of report 2024-09-15 · accession 0001724521-24-000149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-17 | 2024-09-15 | RCUS | Nuyten Dimitry SA | Chief Medical Off | F - Tax | $17.95 | -5,385 | 94.9K | -5% | -$96.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-15 | F | D | 5,385 | $17.95 | 94,933 | D | — | — | (F1) Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. (F2) Includes 1,123 shares purchased on 5/31/2024 through the Company's Employee Stock Purchase Plan. |